Treatment of idiopathic intracranial hypertension is aimed at the following: Reducing pressure Preserving vision Relieving symptoms The carbonic anhydrase inhibitor acetazolamide (250 mg orally 4 times a day) or topiramate (which also inhibits carbonic anhydrase) up to 200 mg twice a day is used.